May 3, 2023
12:45 to 14:00 ET
Centre Mont-Royal, Salon Mont-Royal II (4th floor)
A Case for Universal Germline Genetic Testing for Newly Diagnosed Breast Cancer and the Impact on Patient Decisions
Universal germline genetic testing for breast cancer has not been standard practice in Canada. Evolving understanding of relevant breast cancer genes and complex provincial testing criteria lead to inequity of testing across Canada and gaps in identification of patients with important genetic variants. In this presentation, Larissa Peck, Genetic Counsellor, will discuss the rationale for Princess Margaret Cancer Centre’s upcoming initiative to offer germline genetic testing to all breast cancer patients. Kelly Metcalfe, Researcher at Women’s College Hospital and PI of the Rapid Genetic Testing for Patients with Newly Diagnosed Breast Cancer study, will share research results on the outcomes associated with genetic testing at the time of breast cancer diagnosis.

Kelly Metcalfe, RN, PhD, FCAHS, FAAN
Senior Scientist, Women’s College Research Institute; Professor and Associate Dean of Research, Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada



Larissa Peck MSc, CGC
Genetic Counsellor, Princess Margaret Cancer Centre, Toronto, ON, Canada




Registration not required.


Sponsored by AstraZeneca and Merck